Hepatocellular carcinoma-specific immunotherapy with synthesized α1,3- galactosyl epitope-pulsed dendritic cells and cytokine-induced killer cells

Table 2 Ratios of post- and pre-immunotherapy in cell populations and interferon-γ expression levels

Patient no.	CD8+post vs pre	CD45RO+post vs pre	CD56+post vs pre	IFN-γfold increasepost vs pre
1	5.09	6.78	4.81	15.32
2	5.22	4.97	5.66	12.25
3	6.33	3.78	4.77	12.45
4	4.81	1.42	1.39	11.11
5	2.15	2.43	2.17	3.88
6	3.67	3.66	5.86	7.94
7	3.78	3.94	2.81	8.31
8	0.55	2.02	0.65	1.03
9	5.23	6.67	3.55	12.73

IFN: Interferon; CD: Cluster of differentiation..